<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36737438</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>03</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Alternative polyadenylation transcriptome-wide association study identifies APA-linked susceptibility genes in brain disorders.</ArticleTitle><Pagination><StartPage>583</StartPage><MedlinePgn>583</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">583</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-36311-8</ELocationID><Abstract><AbstractText>Alternative polyadenylation (APA) plays an essential role in brain development; however, current transcriptome-wide association studies (TWAS) largely overlook APA in nominating susceptibility genes. Here, we performed a 3' untranslated region (3'UTR) APA TWAS (3'aTWAS) for 11 brain disorders by combining their genome-wide association studies data with 17,300 RNA-seq samples across 2,937 individuals. We identified 354 3'aTWAS-significant genes, including known APA-linked risk genes, such as SNCA in Parkinson's disease. Among these 354 genes, ~57% are not significant in traditional expression- and splicing-TWAS studies, since APA may regulate the translation, localization and protein-protein interaction of the target genes independent of mRNA level expression or splicing. Furthermore, we discovered ATXN3 as a 3'aTWAS-significant gene for amyotrophic lateral sclerosis, and its modulation substantially impacted pathological hallmarks of amyotrophic lateral sclerosis in vitro. Together, 3'aTWAS is a powerful strategy to nominate important APA-linked brain disorder susceptibility genes, most of which are largely overlooked by conventional expression and splicing analyses.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cui</LastName><ForeName>Ya</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1574-0928</Identifier><AffiliationInfo><Affiliation>Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Arnold</LastName><ForeName>Frederick J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0003-1927-264X</Identifier><AffiliationInfo><Affiliation>Departments of Pathology &amp; Laboratory Medicine, Neurology, and Biological Chemistry, School of Medicine, and the UCI Institute for Neurotherapeutics, University of California Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Fanglue</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8818-3785</Identifier><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, University Baylor College of Medicine, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0313-5528</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jason Sheng</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0003-0485-7194</Identifier><AffiliationInfo><Affiliation>Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michels</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9265-9034</Identifier><AffiliationInfo><Affiliation>Departments of Pathology &amp; Laboratory Medicine, Neurology, and Biological Chemistry, School of Medicine, and the UCI Institute for Neurotherapeutics, University of California Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-0217-383X</Identifier><AffiliationInfo><Affiliation>School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Spada</LastName><ForeName>Albert R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-6151-2964</Identifier><AffiliationInfo><Affiliation>Departments of Pathology &amp; Laboratory Medicine, Neurology, and Biological Chemistry, School of Medicine, and the UCI Institute for Neurotherapeutics, University of California Irvine, Irvine, CA, 92697, USA. alaspada@hs.uci.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-9931-5990</Identifier><AffiliationInfo><Affiliation>Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, Irvine, CA, 92697, USA. wei.li@uci.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 NS122140</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061356</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG032984</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG048015</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG036836</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000096</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS122140</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA228140</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA193466</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026723" MajorTopicYN="N">Polyadenylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="N">3' Untranslated Regions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36737438</ArticleId><ArticleId IdType="pmc">PMC9898543</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-36311-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-36311-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoque M, et al. Analysis of alternative cleavage and polyadenylation by 3&#x2019; region extraction and deep sequencing. Nat. Methods. 2013;10:133&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3560312</ArticleId><ArticleId IdType="pubmed">23241633</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Nambiar R, Zheng D, Tian B. PolyA_DB 3 catalogs cleavage and polyadenylation sites identified by deep sequencing in multiple genomes. Nucleic Acids Res. 2018;46:D315&#x2013;D319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753232</ArticleId><ArticleId IdType="pubmed">29069441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian B, Manley JL. Alternative polyadenylation of mRNA precursors. Nat. Rev. Mol. Cell Biol. 2017;18:18&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5483950</ArticleId><ArticleId IdType="pubmed">27677860</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura P, Sanfilippo P, Shenker S, Lai EC. Alternative polyadenylation in the nervous system: to what lengths will 3&#x2019; UTR extensions take us? Bioessays. 2014;36:766&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4503322</ArticleId><ArticleId IdType="pubmed">24903459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgers V, et al. Neural-specific elongation of 3&#x2019; UTRs during Drosophila development. Proc. Natl Acad. Sci. USA. 2011;108:15864&#x2013;15869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179109</ArticleId><ArticleId IdType="pubmed">21896737</ArticleId></ArticleIdList></Reference><Reference><Citation>Smibert P, et al. Global patterns of tissue-specific alternative polyadenylation in Drosophila. Cell Rep. 2012;1:277&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3368434</ArticleId><ArticleId IdType="pubmed">22685694</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W, et al. APAatlas: decoding alternative polyadenylation across human tissues. Nucleic Acids Res. 2020;48:D34&#x2013;D39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943053</ArticleId><ArticleId IdType="pubmed">31586392</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard PJ, et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA. 2011;17:761&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3062186</ArticleId><ArticleId IdType="pubmed">21343387</ArticleId></ArticleIdList></Reference><Reference><Citation>Romo L, Ashar-Patel A, Pfister E, Aronin N. Alterations in mRNA 3&#x2019; UTR isoform abundance accompany gene expression changes in human Huntington&#x2019;s disease brains. Cell Rep. 2017;20:3057&#x2013;3070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625827</ArticleId><ArticleId IdType="pubmed">28954224</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinn H, et al. Alternative alpha-synuclein transcript usage as a convergent mechanism in Parkinson&#x2019;s disease pathology. Nat. Commun. 2012;3:1084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3660047</ArticleId><ArticleId IdType="pubmed">23011138</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenal M, et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell. 2012;149:538&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">22502866</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennarino VA, et al. NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation. Elife. 2015;4:e10782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586391</ArticleId><ArticleId IdType="pubmed">26312503</ArticleId></ArticleIdList></Reference><Reference><Citation>Masamha CP, et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature. 2014;510:412&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4128630</ArticleId><ArticleId IdType="pubmed">24814343</ArticleId></ArticleIdList></Reference><Reference><Citation>Demontis D, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 2019;51:63&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6481311</ArticleId><ArticleId IdType="pubmed">30478444</ArticleId></ArticleIdList></Reference><Reference><Citation>Grove J, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 2019;51:431&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454898</ArticleId><ArticleId IdType="pubmed">30804558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins N, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 2021;53:817&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192451</ArticleId><ArticleId IdType="pubmed">34002096</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard DM, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 2019;22:343&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522363</ArticleId><ArticleId IdType="pubmed">30718901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardinas AF, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 2018;50:381&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5918692</ArticleId><ArticleId IdType="pubmed">29483656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman DP, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x2019;s disease. Nat. Genet. 2021;53:1276&#x2013;1282.</Citation><ArticleIdList><ArticleId IdType="pubmed">34493870</ArticleId></ArticleIdList></Reference><Reference><Citation>Claussnitzer M, et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 2015;373:895&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4959911</ArticleId><ArticleId IdType="pubmed">26287746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachmazidou I, et al. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. Nat. Genet. 2019;51:230&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6400267</ArticleId><ArticleId IdType="pubmed">30664745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois PC, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 2010;42:295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847618</ArticleId><ArticleId IdType="pubmed">20190752</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffatt MF, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448:470&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">17611496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson&#x2019;s disease risk loci. Nat. Genet. 2017;49:1511&#x2013;1516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5812477</ArticleId><ArticleId IdType="pubmed">28892059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng B, et al. An xQTL map integrates the genetic architecture of the human brain&#x2019;s transcriptome and epigenome. Nat. Neurosci. 2017;20:1418&#x2013;1426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5785926</ArticleId><ArticleId IdType="pubmed">28869584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, et al. Comprehensive functional genomic resource and integrative model for the human brain. Science. 2018;362:eaat8464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6413328</ArticleId><ArticleId IdType="pubmed">30545857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet. 2018;50:956&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248311</ArticleId><ArticleId IdType="pubmed">29955180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao DW, O&#x2019;Connor LJ, Price AL, Gusev A. Quantifying genetic effects on disease mediated by assayed gene expression levels. Nat. Genet. 2020;52:626&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276299</ArticleId><ArticleId IdType="pubmed">32424349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 2015;47:1091&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552594</ArticleId><ArticleId IdType="pubmed">26258848</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 2016;48:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">27019110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev A, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 2016;48:245&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4767558</ArticleId><ArticleId IdType="pubmed">26854917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, et al. A statistical framework for cross-tissue transcriptome-wide association analysis. Nat. Genet. 2019;51:568&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788740</ArticleId><ArticleId IdType="pubmed">30804563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, et al. A unified framework for joint-tissue transcriptome-wide association and Mendelian randomization analysis. Nat. Genet. 2020;52:1239&#x2013;1246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606598</ArticleId><ArticleId IdType="pubmed">33020666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainberg M, et al. Opportunities and challenges for transcriptome-wide association studies. Nat. Genet. 2019;51:592&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6777347</ArticleId><ArticleId IdType="pubmed">30926968</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GT, et al. Genetic effects on gene expression across human tissues. Nature. 2017;550:204&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5776756</ArticleId><ArticleId IdType="pubmed">29022597</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, et al. An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability. Nat. Genet. 2021;53:994&#x2013;1005.</Citation><ArticleIdList><ArticleId IdType="pubmed">33986536</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CY, et al. Genome-wide landscape of RNA-binding protein target site dysregulation reveals a major impact on psychiatric disorder risk. Nat. Genet. 2021;53:166&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886016</ArticleId><ArticleId IdType="pubmed">33462483</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Z, et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3&#x2019;-UTR landscape across seven tumour types. Nat. Commun. 2014;5:5274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467577</ArticleId><ArticleId IdType="pubmed">25409906</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Li L, Wagner EJ, Li W. TC3A: the Cancer 3&#x2019; UTR Atlas. Nucleic Acids Res. 2018;46:D1027&#x2013;D1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753254</ArticleId><ArticleId IdType="pubmed">30053266</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegle O, Parts L, Piipari M, Winn J, Durbin R. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc. 2012;7:500&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3398141</ArticleId><ArticleId IdType="pubmed">22343431</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabalin AA. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012;28:1353&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3348564</ArticleId><ArticleId IdType="pubmed">22492648</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte F, et al. Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts. Hum. Genet. 2016;135:41&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4698300</ArticleId><ArticleId IdType="pubmed">26561393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, et al. 3&#x2019;aQTL-atlas: an atlas of 3&#x2019;UTR alternative polyadenylation quantitative trait loci across human normal tissues. Nucleic Acids Res. 2022;50:D39&#x2013;D45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728222</ArticleId><ArticleId IdType="pubmed">34432052</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YI, Wong G, Humphrey J, Raj T. Prioritizing Parkinson&#x2019;s disease genes using population-scale transcriptomic data. Nat. Commun. 2019;10:994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6397174</ArticleId><ArticleId IdType="pubmed">30824768</ArticleId></ArticleIdList></Reference><Reference><Citation>Iotchkova V, et al. GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat. Genet. 2019;51:343&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6908448</ArticleId><ArticleId IdType="pubmed">30692680</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorp JG, et al. Symptom-level modelling unravels the shared genetic architecture of anxiety and depression. Nat. Hum. Behav. 2021;5:1432&#x2013;1442.</Citation><ArticleIdList><ArticleId IdType="pubmed">33859377</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein MB, et al. Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Program. Nat. Genet. 2021;53:174&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7972521</ArticleId><ArticleId IdType="pubmed">33510476</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig IR. Challenges in disentangling the genetic background of Parkinson&#x2019;s disease. Lancet Neurol. 2019;18:1069&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">31701887</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. Nat. Med. 2016;22:649&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">27158905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso N, et al. Probabilistic fine-mapping of transcriptome-wide association studies. Nat. Genet. 2019;51:675&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6619422</ArticleId><ArticleId IdType="pubmed">30926970</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Sarkar A. A simple new approach to variable selection in regression, with application to genetic fine-mapping. J. R. Stat. Soc. Ser. B (Stat. Methodol.) 2020;82:1273&#x2013;1300.</Citation></Reference><Reference><Citation>Nicolas E, et al. CAMOS, a nonprogressive, autosomal recessive, congenital cerebellar ataxia, is caused by a mutant zinc-finger protein, ZNF592. Eur. J. Hum. Genet. 2010;18:1107&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2987462</ArticleId><ArticleId IdType="pubmed">20531441</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler KM, et al. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain. 2018;141:2392&#x2013;2405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6061692</ArticleId><ArticleId IdType="pubmed">29961870</ArticleId></ArticleIdList></Reference><Reference><Citation>Edenberg HJ, Foroud T. Genetics and alcoholism. Nat. Rev. Gastroenterol. Hepatol. 2013;10:487&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056340</ArticleId><ArticleId IdType="pubmed">23712313</ArticleId></ArticleIdList></Reference><Reference><Citation>McGlinchey RP, Lee JC. Cysteine cathepsins are essential in lysosomal degradation of alpha-synuclein. Proc. Natl Acad. Sci. USA. 2015;112:9322&#x2013;9327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522768</ArticleId><ArticleId IdType="pubmed">26170293</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys. Res. Commun. 2006;351:602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, et al. A scored human protein-protein interaction network to catalyze genomic interpretation. Nat. Methods. 2017;14:61&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839635</ArticleId><ArticleId IdType="pubmed">27892958</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Levine B. Autophagy in human diseases. N. Engl. J. Med. 2020;383:1564&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pubmed">33053285</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini-Stoica H, Xu Y, Ballabio A, Zheng H. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016;39:221&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928589</ArticleId><ArticleId IdType="pubmed">26968346</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Meco A, Curtis ME, Lauretti E, Pratico D. Autophagy dysfunction in Alzheimer&#x2019;s disease: mechanistic insights and new therapeutic opportunities. Biol. Psychiatry. 2020;87:797&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">31262433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Chan CC, Cherry S, Hiesinger PR. Membrane trafficking in neuronal maintenance and degeneration. Cell Mol. Life Sci. 2013;70:2919&#x2013;2934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722462</ArticleId><ArticleId IdType="pubmed">23132096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiral FR, Kohrs FE, Jin EJ, Hiesinger PR. Rab GTPases and membrane trafficking in neurodegeneration. Curr. Biol. 2018;28:R471&#x2013;R486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5965285</ArticleId><ArticleId IdType="pubmed">29689231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa T, Sugeno N, Kikuchi A, Baba T, Aoki M. Membrane trafficking illuminates a path to Parkinson&#x2019;s disease. Tohoku J. Exp. Med. 2017;242:63&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">28539529</ArticleId></ArticleIdList></Reference><Reference><Citation>Winckler B, et al. The endolysosomal system and proteostasis: from development to degeneration. J. Neurosci. 2018;38:9364&#x2013;9374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6209849</ArticleId><ArticleId IdType="pubmed">30381428</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos CA, et al. Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models. J. Cell Biol. 2016;212:465&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754714</ArticleId><ArticleId IdType="pubmed">26880203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong X, Pittman RN. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet. 2006;15:2409&#x2013;2420.</Citation><ArticleIdList><ArticleId IdType="pubmed">16822850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Ying Z, Wang G. Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains. J. Biol. Chem. 2012;287:28576&#x2013;28585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3436588</ArticleId><ArticleId IdType="pubmed">22761419</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;b U, Brunt ER, Deller T. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease) Curr. Opin. Neurol. 2008;21:111&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">18317266</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, et al. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol. 2009;118:553&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">19526244</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giammartino DC, Nishida K, Manley JL. Mechanisms and consequences of alternative polyadenylation. Mol. Cell. 2011;43:853&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3194005</ArticleId><ArticleId IdType="pubmed">21925375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber AJ, Zavolan M. Alternative cleavage and polyadenylation in health and disease. Nat. Rev. Genet. 2019;20:599&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">31267064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittleman BE, et al. Alternative polyadenylation mediates genetic regulation of gene expression. Elife. 2020;9:e57492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338057</ArticleId><ArticleId IdType="pubmed">32584258</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaid DJ, Chen W, Larson NB. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 2018;19:491&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050137</ArticleId><ArticleId IdType="pubmed">29844615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hormozdiari F, et al. Colocalization of GWAS and eQTL signals detects target genes. Am. J. Hum. Genet. 2016;99:1245&#x2013;1260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5142122</ArticleId><ArticleId IdType="pubmed">27866706</ArticleId></ArticleIdList></Reference><Reference><Citation>Benner C, et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics. 2016;32:1493&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4866522</ArticleId><ArticleId IdType="pubmed">26773131</ArticleId></ArticleIdList></Reference><Reference><Citation>Abell NS, et al. Multiple causal variants underlie genetic associations in humans. Science. 2022;375:1247&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9725108</ArticleId><ArticleId IdType="pubmed">35298243</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogard N, Linder J, Rosenberg AB, Seelig G. A deep neural network for predicting and engineering alternative polyadenylation. Cell. 2019;178:91&#x2013;106.e123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599575</ArticleId><ArticleId IdType="pubmed">31178116</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J, et al. CRISPRpas: programmable regulation of alternative polyadenylation by dCas9. Nucleic Acids Res. 2022;50:e25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934653</ArticleId><ArticleId IdType="pubmed">34244761</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, et al. CRISPR-iPAS: a novel dCAS13-based method for alternative polyadenylation interference. Nucleic Acids Res. 2022;50:e26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934656</ArticleId><ArticleId IdType="pubmed">35191504</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiedel BJ, et al. Impact of genetic polymorphisms on human immune. Cell Gene Expr. Cell. 2018;175:1701&#x2013;1715.e1716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289654</ArticleId><ArticleId IdType="pubmed">30449622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodes RJ, Buckholtz N. Accelerating medicines partnership: Alzheimer&#x2019;s disease (AMP-AD) knowledge portal aids Alzheimer&#x2019;s drug discovery through open data sharing. Expert Opin. Ther. Targets. 2016;20:389&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">26853544</ArticleId></ArticleIdList></Reference><Reference><Citation>Chibnik LB, et al. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Mol. Psychiatry. 2018;23:1521&#x2013;1529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608624</ArticleId><ArticleId IdType="pubmed">28322283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj T, et al. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer&#x2019;s disease susceptibility. Nat. Genet. 2018;50:1584&#x2013;1592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6354244</ArticleId><ArticleId IdType="pubmed">30297968</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandal MJ, et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science. 2018;362:eaat8127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6443102</ArticleId><ArticleId IdType="pubmed">30545856</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832824</ArticleId><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA. 2003;100:9440&#x2013;9445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC170937</ArticleId><ArticleId IdType="pubmed">12883005</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl EA, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 2019;51:793&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6956732</ArticleId><ArticleId IdType="pubmed">31043756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat. Genet. 2019;51:404&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hormozdiari F, et al. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits. Nat. Genet. 2018;50:1041&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030458</ArticleId><ArticleId IdType="pubmed">29942083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, et al. Genetic analyses support the contribution of mRNA N(6)-methyladenosine (m(6)A) modification to human disease heritability. Nat. Genet. 2020;52:939&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483307</ArticleId><ArticleId IdType="pubmed">32601472</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeira AN, et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 2018;9:1825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5940825</ArticleId><ArticleId IdType="pubmed">29739930</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen LJ, et al. STRING 8&#x2014;a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009;37:D412&#x2013;D416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2686466</ArticleId><ArticleId IdType="pubmed">18940858</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>